TP53 and breast cancer: Intriguingly, Case 7 also carried a TP53 duplication variant (EX2_6 Dup), which was defined as ‘uncertain significance,’ and her phenotype (early onset bilateral breast cancer and recurrent chest wall sarcomas) was highly consistent with that of TP53 carriers, which suggests the variant is associated with cancer predisposition.